Scarica l'app Stockscreener
3.22
7.74%
-0.27
Dopo l'orario di chiusura:
3.25
0.03
+0.93%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SANA Giù?
Forum
Previsione
Sana Biotechnology Inc Borsa (SANA) Ultime notizie
Sana Biotechnology (NASDAQ:SANA) Trading Down 6.2%What's Next? - MarketBeat
Sana Biotechnology (NASDAQ:SANA) Shares Up 8.8%Time to Buy? - MarketBeat
Vanguard Group Inc. Reduces Stake in Sana Biotechnology Inc. - GuruFocus.com
Retail Traders Flocked To These 5 Biotech Stocks In January — Here’s Why - Asianet Newsable
Sana Biotechnology, Inc. (SANA): A Bull Case Theory - Insider Monkey
Sana Biotechnology (NASDAQ:SANA) Shares Up 13.9%Time to Buy? - MarketBeat
Flagship Pioneering, Cambridge University Health Partners, and Milner Therapeutics Institute Announce Collaboration to Accelerate Biotech Research and Innovation - Quantisnow
Sana Biotech extends rally as Morgan Stanley cites platform's potential - MSN
Vir, Sana gain new modality POC: BioCentury’s Clinical Report - BioCentury
Sana Biotechnology (NASDAQ:SANA) Trading Down 6.5%Here's Why - MarketBeat
Sana Biotechnology (NASDAQ:SANA) Trading 13.9% HigherHere's Why - MarketBeat
Is Sana Biotechnology, Inc. (SANA) the Hottest Smid-Cap Stock So Far In 2025? - MSN
There May Still Be Time to Get in on These 3 Trending Biotechs - MarketBeat
Sana Biotechnology Inc (SANA-Q) QuotePress Release - The Globe and Mail
JPMorgan Chase & Co. Cuts Stock Position in Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Sana stock rallies 280% on pancreatic cell transplant study - MSN
Sana Biotechnology (NASDAQ:SANA) Shares Gap DownShould You Sell? - MarketBeat
Sana Biotechnology (NASDAQ:SANA) Trading Down 5.5%Here's Why - MarketBeat
Layoff Tracker: Notch Therapeutics to ‘Significantly Reduce’ Workforce - BioSpace
As researchers push for a type 1 diabetes cure, Sana Biotechnology provides a nudge forward - STAT
Sana Biotechnology (NASDAQ:SANA) Shares Down 5.5%Here's What Happened - MarketBeat
Sana Biotechnology (NASDAQ:SANA) Stock Price Up 5.7%Here's Why - MarketBeat
Sana Biotechnology price target raised to $12 from $9 at Morgan Stanley - MSN
SANA Stock Surges 152% in a Week on Upbeat Initial Diabetes Study Data - MSN
Sana Biotechnology (NASDAQ:SANA) Shares Up 5.7%Time to Buy? - MarketBeat
This Biotech Penny Stock Is Up 120% This Year. Analysts Think It Can Still Triple From Here in 2025. - MSN
Sana Biotechnology Shows Promise with Hypoimmune Platform - TipRanks
Sana Biotechnology, Inc. (NASDAQ:SANA) Shares Purchased by Barclays PLC - MarketBeat
Sana Biotechnology (NASDAQ:SANA) Shares Gap Up – Here’s What Happened - Defense World
Sana Biotechnology (NASDAQ:SANA) Price Target Raised to $11.00 - Defense World
FMR LLC sells $1.89 million in Sana Biotechnology shares By Investing.com - Investing.com South Africa
SANA Stock Surges 152% In A Week On Upbeat Initial Diabetes Study Data - Barchart
FMR LLC Reduces Holdings in Sana Biotechnology Inc - GuruFocus.com
Insider Selling: Sana Biotechnology, Inc. (NASDAQ:SANA) Insider Sells 290,912 Shares of Stock - MarketBeat
FMR LLC sells $1.89 million in Sana Biotechnology shares - Investing.com India
Sana Biotechnology (NASDAQ:SANA) Shares Gap UpHere's What Happened - MarketBeat
Top 2 Health Care Stocks That Are Ticking Portfolio Bombs - Benzinga
Sana Biotechnology could offer relief to diabetes type 1 sufferers in the future - Mugglehead
Shares of Sana soar following breakthrough in diabetes therapy trials - Kursiv Media
Sana Biotech Stock Triples After Type 1 Diabetes Trial Wows Analysts: Retail Erupts In Excitement - NewsBreak
Cowen Pounds the Table on Sana Biotechnology Stock - TipRanks
This Biotech Stock Just Soared 240%. Why It Can Go Higher. - MSN
First data for immune-evading type 1 diabetes therapy trigger Sana stock surge - FirstWord Pharma
Biotech Breakthroughs: Sana Biotechnology (NASDAQ: SANA) Type - openPR
Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance - BioWorld Online
Sana Biotechnology to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
3.95%
2.39%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):